RETRACTED ARTICLE: MiR-616 plays oncogenic role in hepatocellular carcinoma progression through suppressing PTEN expression and activating PI3K/AKT pathway
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Rina Sa, Huali Song, Meihua Wei, Hailong Su, Yao Hong, Lulu Zhou, & Yunfei Bai (2020) MiR-616 plays oncogenic role in hepatocellular carcinoma progression through suppressing PTEN expression and activating PI3K/AKT pathway. Artificial Cells, Nanomedicine, and Biotechnology, 48:1, 728–734. DOI: 10.1080/21691401.2019.1596928.It has come to our attention that the full authorship list and affiliations for this manuscript were changed after the article was accepted. We have contacted the corresponding author for an explanation, but we have not received a response. As determining authorship is core to the integrity of pubished work, we are therefore retracting the article. The corresponding author listed in this publication has been informed.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Gastroenterology and Endocrinology, The 263th Clinical Department, Chinese PLA General Hospital, Beijing, China
References
Reference metadata was not supplied for this record.